- Report
- March 2025
- 200 Pages
Global
From €2199EUR$2,490USD£1,879GBP
- Report
- October 2024
- 244 Pages
Global
From €7021EUR$7,950USD£5,998GBP
- Report
- October 2024
- 237 Pages
Global
From €7021EUR$7,950USD£5,998GBP
- Report
- January 2019
- 144 Pages
Global
From €2429EUR$2,750USD£2,075GBP
- Report
- May 2024
- 133 Pages
Global
From €5740EUR$6,499USD£4,903GBP
- Report
- February 2023
- 220 Pages
Global
From €6624EUR$7,500USD£5,658GBP
Diovan is a cardiovascular drug used to treat high blood pressure, heart failure, and other conditions. It is a type of angiotensin receptor blocker (ARB) that works by blocking the action of certain natural substances that tighten the blood vessels, allowing the blood to flow more smoothly and the heart to pump more efficiently. Diovan is also used to reduce the risk of stroke in people with high blood pressure and left ventricular hypertrophy, a condition in which the walls of the left ventricle of the heart become thickened.
Diovan is available in both generic and brand-name versions. It is available in tablet form and is taken orally. It is also available in combination with other drugs, such as hydrochlorothiazide, to treat high blood pressure.
The Diovan market is highly competitive, with many companies offering generic and brand-name versions of the drug. Some of the companies in the market include Novartis, Mylan, Teva Pharmaceuticals, Sandoz, and Sun Pharmaceuticals. Show Less Read more